Vyome Holdings, Inc. (HIND) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.36
• Market Cap: $19.54M
• EPS: $-0.21
• 52-Week High: $159.00
• 52-Week Low: $1.75

About Vyome Holdings, Inc.

Vyome Holdings, Inc. (Ticker: HIND) is a clinical-stage biopharmaceutical company focused on developing innovative therapeutic solutions for immuno-inflammatory and rare diseases. Based in Princeton, New Jersey, Vyome leverages cutting-edge research and advanced technologies to address unmet medical needs in the United States and international markets. The company's pipeline emphasizes its commitment to delivering impactful treatments, positioning it as a key player in the evolving landscape ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vyome Holdings, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HIND pay dividends?

Vyome Holdings, Inc. (HIND) does not currently pay a regular dividend.

What is HIND's market cap?

Vyome Holdings, Inc. (HIND) has a market capitalization of $19.54M with a current stock price of $3.36.